(Q35060005)

6 August 2017

1 reference

title

New strategies for prevention and treatment of graft-versus-host disease and for induction of graft-versus-leukemia effects (English)

1 reference

6 August 2017

1

H Joachim Deeg

1 reference

6 August 2017

publication date

1 January 2003

1 reference

International Journal of Hematology

6 August 2017

published in

1 reference

6 August 2017

volume

77

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

15-21

1 reference

Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02982598

Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02982598

Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02982598

TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II-disparate (C57BL/6J-->C57BL/6J x bm12)F1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02982598

In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02982598

Hematopoietic system-specific antigens as targets for cellular immunotherapy of hematological malignancies

21 January 2018

1 reference

12 December 2020

Acute graft-versus-host disease: inflammation run amok?

1 reference

12 December 2020

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

1 reference

12 December 2020

Cellular and cytokine effectors of acute graft versus host disease

1 reference

12 December 2020

The gut mucosa barrier is preserved during allogeneic, haemopoietic stem cell transplantation with reduced intensity conditioning

1 reference

12 December 2020

Mechanisms of tolerance induced by PG490-88 in a bone marrow transplantation model

1 reference

12 December 2020

Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants

1 reference

12 December 2020

Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft

1 reference

12 December 2020

Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

Opposing roles of interferon-gamma on CD4+ T cell-mediated graft-versus-host disease: effects of conditioning

1 reference

12 December 2020

Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease

1 reference

12 December 2020

The biology of graft-versus-host reactions

1 reference

12 December 2020

Infusion of select leukemia-reactive TCR Vbeta+ T cells provides graft-versus-leukemia responses with minimization of graft-versus-host disease following murine hematopoietic stem cell transplantation

1 reference

12 December 2020

LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation

1 reference

12 December 2020

Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect

1 reference

12 December 2020

CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade

1 reference

12 December 2020

Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells.

1 reference

12 December 2020

Flt3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD8 alpha(+) dendritic cells and reduces experimental acute graft-versus-host disease

1 reference

12 December 2020

A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease

1 reference

12 December 2020

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

1 reference

12 December 2020

Immunological reconstitution and immunoregulatory cells in hematopoietic stem cell transplantation

1 reference

12 December 2020

Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL.

1 reference

12 December 2020

Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue

1 reference

12 December 2020

Pathophysiologic mechanisms of acute graft-vs.-host disease

1 reference

12 December 2020

A metalloproteinase inhibitor prevents acute graft-versus-host disease while preserving the graft-versus-leukaemia effect of allogeneic bone marrow transplantation

1 reference

12 December 2020

Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis

1 reference

12 December 2020

Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final result

1 reference

12 December 2020

Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation

1 reference

12 December 2020

Expression of HLA-C-specific natural killer cell receptors (CD158a and CD158b) on peripheral blood mononuclear cells after allogeneic bone marrow transplantation

1 reference

12 December 2020

Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation

1 reference

12 December 2020

Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process

1 reference

12 December 2020

A contemporary view of transplantation tolerance: an immunologist's perspective

1 reference

12 December 2020

Dose and timing of interleukin (IL)-12 and timing and type of total-body irradiation: effects on graft-vs.-host disease inhibition and toxicity of exogenous IL-12 in murine bone marrow transplant recipients

1 reference

12 December 2020

Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice

1 reference

12 December 2020

CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling tr

1 reference

12 December 2020

Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia

1 reference

12 December 2020

Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells

1 reference

12 December 2020

Flt3 ligand (FL) treatment of murine donors does not modify graft-versus-host disease (GVHD) but FL treatment of recipients post-bone marrow transplantation accelerates GVHD lethality

1 reference

12 December 2020

Understanding the alloresponse: new approaches to graft-versus-host disease prevention.

1 reference

12 December 2020

IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.

1 reference

12 December 2020

Major histocompatibility complex-mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4(+) donor T cells: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease path

1 reference

12 December 2020

Cytokines in graft-versus-host disease and the graft-versus-leukemia reaction

1 reference

12 December 2020

Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation

1 reference

12 December 2020

Prolonged secretion of IL-15 in patients with severe forms of acute graft-versus-host disease after allogeneic bone marrow transplantation in children

1 reference

12 December 2020

Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG).

1 reference

12 December 2020

Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives

1 reference

12 December 2020

Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation

1 reference

12 December 2020

Donor natural killer (NK1.1+) cells do not play a role in the suppression of GVHD or in the mediation of GVL reactions after DLI

1 reference

12 December 2020

Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation

1 reference

12 December 2020

Janus kinase 3 inhibitor WHI-P131/JANEX-1 prevents graft-versus-host disease but spares the graft-versus-leukemia function of the bone marrow allografts in a murine bone marrow transplantation model

1 reference

12 December 2020

Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease

1 reference

12 December 2020

Cellular therapy: exploiting NK cell alloreactivity in transplantation

1 reference

12 December 2020

The role of interleukin-12 and interferon-gamma in GVHD and GVL.

1 reference

12 December 2020

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

12 December 2020

Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation

1 reference

12 December 2020

Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies

1 reference

12 December 2020

CD28-specific antibody prevents graft-versus-host disease in mice

1 reference

12 December 2020

Acute graft-versus-host disease does not require alloantigen expression on host epithelium

1 reference

12 December 2020

Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease: a model system for the reversal of disease

1 reference

12 December 2020

Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study.

1 reference

12 December 2020

Separate ontogeny of two macrophage-like accessory cell populations in the human fetus

1 reference

12 December 2020

Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis

1 reference

12 December 2020

Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells

1 reference

12 December 2020

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02982598

1 reference

6 August 2017

1 reference